CD4 < sup > + < /sup > CD25 < sup > + < /sup > CD127 < sup > low < /sup > regulatory T cells associated with the effect of CD19 CAR-T therapy for relapsed/refractory B-cell acute lymphoblastic leukemia

CONCLUSION: Higher circulating Tregs, especially 1 week after CD19 CAR-T cell infusion, was a poor predict indicator for CD19 CAR-T therapy in R/R B-ALL patients.PMID:33984717 | DOI:10.1016/j.intimp.2021.107742

Source: International Immunopharmacology - May 13, 2021 Category: Allergy & Immunology Authors: Ying Pan Huiping Wang Furun An Fan Wu Qianshan Tao Yingwei Li Yanjie Ruan Zhimin Zhai Source Type: research